High materiality7/10
Celestica upgraded to Buy from Neutral at UBS
Why it may matterVerify against the original reporting
UBS upgrade to Buy implies bullish upside potential on CLS with a substantial price target.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
UBS upgrades Celestica (CLS) to Buy from Neutral and sets a target price of $430, signaling meaningful upside from the current price of $296.55.
- UBS upgrades CLS to Buy; target $430 (from $296.55).
Key facts
- 01
Target: $430
- 02
Posted price: $296.55
- 03
Analyst firm: UBS
- 04
Analyst: David Vogt
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.